Search
Searching Content indexed under Patent by Corrs Chambers Westgarth ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Motorola v Hytera update: discovery, state security laws and copyright infringement in issue in digital mobile radio patent dispute
Further developments in the patent infringement proceedings between Motorola and Hytera are discussed here.
Australia
30 Jan 2019
2
Winning the battle but not the war: Federal Court clarifies how damages undertakings will be enforced when an injunction is wrongly granted
The case considers compensation payable for wrongly-granted interlocutory injunctions in a pharmaceutical patent dispute.
Australia
26 Nov 2018
3
Power and purpose: Protecting a competitive position after ACCC v Pfizer
This judgment does provide some clarity on the issue of anti-competitive purpose, for pharmaceutical patent owners.
Australia
4 Aug 2018
4
Motorola v Hytera: Standard essential patents to be considered by Federal Court
Standard essential patents are patents for inventions that have been incorporated into one or more industry standards.
Australia
23 Jan 2018
5
Change in the air for IP laws in Australia: 5 key takeaways
This article is an overview of key proposed IP changes, the likely impact and five takeaways for your organisation.
Australia
13 Sep 2017
6
Is the fragmented approach to intellectual property in Australia about to end?
The Productivity Commission delivered a range of recommendations in its report on intellectual property arrangements.
Australia
28 Jun 2017
7
Experimental evidence in patent cases: Discovery not available for experiments on matters no longer in issue
This recent Federal Court decision sheds some light on experimental evidence and discovery in patent cases.
Australia
2 Sep 2016
8
Ensure your R&D activities are not criminal activities
Companies and research institutions involved in cutting-edge research and development may be affected by this DTC Act.
Australia
17 May 2016
9
A myriad of considerations: The High Court finds gene patent invalid
This article highlights key points from the decision and suggests some implications of a wider test for patentability.
Australia
21 Oct 2015
10
High Court upholds finding that Crestor patent is invalid
The Court held that an AstraZeneca patent relating to the blockbuster statin drug CRESTOR (rosuvastatin) was invalid.
Australia
16 Sep 2015
11
The Miles Review of the Cooperative Research Centres Programme - CRCs to stay, with a new, more targeted focus
The Miles Review of the CRCs has been released and all 18 of the recommendations have been accepted by the Government.
Australia
29 May 2015
12
The right to exploit a patent is a single indivisible right - Full Federal Court confirms
If a licensee is intended to have the right to enforce a patent in its own name, careful contractual drafting is needed.
Australia
5 Mar 2015
13
Equivocally bioequivalent - the Federal Court opens the door for consumer law challenges of generic medicines by innovators
This decision may allow innovators to block the launch of certain generics, even without a claim of patent infringement.
Australia
2 Feb 2015
14
Full Court takes a non-literal approach to s145 of the Patents Act - commercial sense prevails
No right to terminate can arise under s145 until all Australian patents the subject of the licence cease to be in force.
Australia
19 Jan 2015
15
Innovators can sleep easy after the High Court's finding that IP Australia has power to extend time for late extension of term patent applications
The High Court's decision upholds IP Australia's ability to grant extensions of time in appropriate circumstances.
Australia
 
18 Nov 2014
16
Generics win the battle for CRESTOR, but lose the war over inventive step
This case places innovators at a significant advantage over generic companies in respect of follow-on inventions.
Australia
 
25 Aug 2014
17
Software patents will not crash the patent system
The Full Federal Court considers if software patents (or computer implemented inventions) are patentable subject matter.
Australia
10 Apr 2014
18
The key to prolonging patent royalty streams
Policy makers should amend s 145 of the Patents Act to address its uncertain application and potential circumvention .
Australia
26 Mar 2014
19
Generic pharmaceuticals and competition law: the ACCC vs Pfizer proceedings
This should provide guidance for patent holders on how to legitimately compete, on the expiry of their exclusive rights.
Australia
12 Mar 2014
Links to Result pages
 
1 2  
>>Next